| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |